Cargando…

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

BACKGROUND: The World Health Organization (WHO) End TB Strategy stresses universal access to drug susceptibility testing (DST). DST determines whether Mycobacterium tuberculosis bacteria are susceptible or resistant to drugs. Xpert MTB/XDR is a rapid nucleic acid amplification test for detection of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pillay, Samantha, Steingart, Karen R, Davies, Geraint R, Chaplin, Marty, De Vos, Margaretha, Schumacher, Samuel G, Warren, Rob, Theron, Grant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115865/ https://www.ncbi.nlm.nih.gov/pubmed/35583175 http://dx.doi.org/10.1002/14651858.CD014841.pub2

Ejemplares similares

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping
por: Venter, Rouxjeane, et al.
Publicado: (2017)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Drug-Resistant Tuberculosis on the Balkan Peninsula: Determination of Drug Resistance Mechanisms with Xpert MTB/XDR and Whole-Genome Sequencing Analysis
por: Truden, Sara, et al.
Publicado: (2023)

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
por: Shapiro, Adrienne E, et al.
Publicado: (2021)

Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk
por: Venter, Rouxjeane, et al.
Publicado: (2020)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones
por: Tang, Peijun, et al.
Publicado: (2018)

Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
por: van Zyl-Smit, Richard N., et al.
Publicado: (2011)

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2022)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert(®) MTB/RIF Ultra and Molbio Truenat(®) MTB Ultima
por: Wood, Rachel C., et al.
Publicado: (2023)

Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation
por: Wang, Xu-De, et al.
Publicado: (2011)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations
por: Ochodo, Eleanor A., et al.
Publicado: (2020)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand
por: Sowajassatakul, Angkanang, et al.
Publicado: (2014)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China
por: Cao, Bin, et al.
Publicado: (2023)

Xpert MTB/RIF Ultra Is Highly Sensitive for the Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting
por: Minnies, Stephanie, et al.
Publicado: (2021)

Ethionamide-induced gynecomastia
por: Dixit, Ramakant, et al.
Publicado: (2012)

Gynecomastia caused by ethionamide
por: Sharma, Parveen K., et al.
Publicado: (2012)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Ectopic Expression of Rv0023 Mediates Isoniazid/Ethionamide Tolerance via Altering NADH/NAD(+) Levels in Mycobacterium smegmatis
por: Gupta, Shailesh Kumar, et al.
Publicado: (2020)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation
por: Ghebrekristos, Yonas T, et al.
Publicado: (2023)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_voe43848mvhkrajae8jjahtarn